Sermorelin
Overview
A synthetic 29-amino acid analog of GHRH representing the shortest fully functional fragment of the native 44-amino acid hormone. Sermorelin stimulates the pituitary to produce and release growth hormone through the natural GHRH receptor pathway, preserving the hypothalamic-pituitary feedback axis.
Mechanism of Action
It maintains physiological pulsatile GH secretion patterns..
Research Summary & Key Findings
FDA-approved for diagnostic evaluation and treatment of growth hormone deficiency in children. Clinical studies demonstrated increases in GH secretion, lean body mass, and improvements in body composition. Shown to improve sleep quality through enhanced slow-wave sleep.
Clinical Status
Sermorelin has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.
Administration Routes
Related Peptides in Hormone
CJC-1295
In Clinical TrialsA synthetic analog of growth hormone-releasing hormone (GHRH) with a Drug Affinity Complex (DAC) that binds to albumin, ...
View detailsIpamorelin
In Clinical TrialsA highly selective growth hormone secretagogue that acts on ghrelin/GHS receptors in the pituitary gland to stimulate GH...
View detailsTesamorelin (Egrifta)
FDA ApprovedA synthetic GHRH analog consisting of the 44-amino acid sequence of human GHRH with a trans-3-hexenoic acid modification...
View detailsPT-141 (Bremelanotide / Vyleesi)
FDA ApprovedA synthetic cyclic heptapeptide melanocortin receptor agonist that activates MC3R and MC4R in the central nervous system...
View detailsFind a Provider
Find a verified provider who offers Sermorelin therapy in your area.
Browse Provider MapFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Sermorelin.
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.